Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372382 · ClinicalTrials.gov registry record · Phase 4
Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 170
- Enrollment target
NCT03372382 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 170 participants.
The verdict
NCT03372382, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 170 participants
- Enrollment target
Study Summary
Postpartum patients delivered by cesarean section will be randomized to NSAIDS Vs NSAIDS plus opioid
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Norco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2018-04-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03372382
The ClinicalTrials.gov registry entry for NCT03372382 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acetaminophen is the first listed.
NCT03372382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03372382 about?
NCT03372382 is a clinical study titled "Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section". Postpartum patients delivered by cesarean section will be randomized to NSAIDS Vs NSAIDS plus opioid
What is the current status of trial NCT03372382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 170 participants. The study started on 2017-12-13. Estimated completion is 2018-04-10.
What interventions are being tested in trial NCT03372382?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Norco (DRUG).
Who is sponsoring clinical trial NCT03372382?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.